TELA Bio (TELA) Net Cash Flow (QoQ) (2019 - 2026)
Powered by 
Analysis
TELA Bio (TELA) Net Cash Flow (QoQ) (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.74 Bn | 175.14 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.56 Bn | 122.34 Bn | 1.96 Bn |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn |
| 4 | Stryker | 103.85 Bn | 100.37 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.70 Bn | 63.16 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.88 Bn | 45.63 Bn | 1.35 Bn |
| 7 | Alcon | 33.04 Bn | 31.59 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 20.65 Bn | 20.17 Bn | 684.20 Mn |
| 10 | TELA Bio | 48.87 Mn | 18.44 Mn | 13.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.81% |
| Mar 31, 2026 | -153.28% |
| Dec 31, 2025 | 493.22% |
| Sep 30, 2025 | 30.13% |
| Jun 30, 2025 | 20.60% |
| Mar 31, 2025 | -127.58% |
| Dec 31, 2024 | 490.66% |
| Sep 30, 2024 | 15.31% |
| Jun 30, 2024 | -10.41% |
| Mar 31, 2024 | 14.17% |
| Dec 31, 2023 | -59.61% |
| Sep 30, 2023 | -120.10% |
| Jun 30, 2023 | 393.43% |
| Mar 31, 2023 | 2.65% |
| Dec 31, 2022 | -145.99% |
| Sep 30, 2022 | 608.40% |
| Jun 30, 2022 | 52.00% |
| Mar 31, 2022 | -12.46% |
| Dec 31, 2021 | -45.65% |
| Sep 30, 2021 | -20.30% |